Home › Research › Long-term cohort studies
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
Hilal S, Wolters FJ, Verbeek MM, Vanderstichele H, Ikram MK, Stoops E, Ikram MA, Vernooij MW.. Alzheimer's research & therapy, 2018-06-30
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Plasma amyloid-β (Aβ) levels are increasingly studied as a potential accessible marker of cognitive impairment and dementia. However, it remains underexplored whether plasma Aβ levels including the novel Aβ peptide 1-38 (Aβ 1-38 ) relate to preclinical markers of neurodegeneration and risk of dementia. We investigated the association of plasma Aβ 1-38 , Aβ 1-40 , and Aβ 1-42 levels with imaging markers of neurodegeneration and risk of dementia in a prospective population-based study.
What this study adds
Evidence grade: Low
The record lists 458 participants. This population-based study investigated whether blood levels of amyloid-beta peptides relate to brain shrinkage and the risk of dementia. Reported effect size: 50.7%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hilal, S., Wolters, F. J., Verbeek, M. M., Vanderstichele, H., Ikram, M. K., Stoops, E., et al. (2018). Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study. Alzheimer's research & therapy. https://doi.org/10.1186/s13195-018-0395-6
Vancouver
Hilal S, Wolters FJ, Verbeek MM, Vanderstichele H, Ikram MK, Stoops E, et al. Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study. Alzheimer's research & therapy. 2018. doi:10.1186/s13195-018-0395-6. PMID: 29960604.
BibTeX
@article{hilal2018-29960604,
author = {Hilal, S. and Wolters, F. J. and Verbeek, M. M. and Vanderstichele, H. and Ikram, M. K. and Stoops, E. and Ikram, M. A. and Vernooij, M. W.},
title = {{Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study}},
journal = {Alzheimer's research \& therapy},
year = {2018},
doi = {10.1186/s13195-018-0395-6},
pmid = {29960604},
url = {https://doi.org/10.1186/s13195-018-0395-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- However, it remains underexplored whether plasma Aβ levels including the novel Aβ peptide 1-38 (Aβ 1-38 ) relate to preclinical markers of neurodegeneration and risk of dementia.
- We investigated the association of plasma Aβ 1-38 , Aβ 1-40 , and Aβ 1-42 levels with imaging markers of neurodegeneration and risk of dementia in a prospective population-based study.
- Methods We analyzed plasma Aβ levels in 458 individuals from the Rotterdam Study.
- Brain volumes, including gray matter, white matter, and hippocampus, were computed on the basis of 1.5-T magnetic resonance imaging (MRI).
Why it matters
This population-based study investigated whether blood levels of amyloid-beta peptides relate to brain shrinkage and the risk of dementia. It does not show that measuring or changing these blood levels prevents or treats Alzheimer's disease.
Study details
- Participants458
- Effect size50.7%
- Evidence strengthLow
How this study scored 51/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer's research & therapy) |
| Journal's citation record | 1 / 4 | Alzheimer s Research & Therapy: journal h-index 146 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 2 / 4 | 458 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 52 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.2 citations a year over 10 year(s) since 2018 |
| Impact for its field and year | 3 / 6 | Cited 4.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 2 / 4 | Cited 15 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Meike Willemijn Vernooij: h-index 99 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 29960604) |
| Free to read | 2 / 2 | Free to read |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s13195-018-0395-6
- PubMed: 29960604
- Original source →
- Free full text: Alzheimer s Research & Therapy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.